mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in patients with antibody deficiency syndromes
Ofer Zimmerman(Washington University in St. Louis), Michael Diamond(Washington University in St. Louis), Harry L. Bertera(Ragon Institute of MGH, MIT and Harvard), Ali H. Ellebedy(Washington University in St. Louis), Fang Zhao(Washington University in St. Louis), Laura A. VanBlargan(Washington University in St. Louis), Rachel M. Presti(Johns Hopkins University), Galit Alter(Ragon Institute of MGH, MIT and Harvard), Chieh-Yu Liang(Washington University in St. Louis), Alexa Michelle Altman Doss(Washington University in St. Louis), Rita E. Chen(Washington University in St. Louis), Tiffany Biason Dy(Washington University in St. Louis), Daved H. Fremont(Washington University in St. Louis), Jackson S. Turner(Washington University in St. Louis), Zhen Ren(Washington University in St. Louis), Paulina Kapłonek(Moderna Therapeutics (United States)), Hannah G. Davis-Adams(Washington University in St. Louis), Peggy L. Kendall(Washington University in St. Louis), Caitlin C. O’Shaughnessy(Washington University in St. Louis), H. James Wedner(Washington University in St. Louis), Anthony Kulczycki(Washington University in St. Louis), Christopher J. Rigell(Washington University in St. Louis), Lucas J. Adams(Washington University in St. Louis), Saravanan Raju(Washington University in St. Louis), Andrew L. Kau(Washington University in St. Louis), Jennifer Monroy(Washington University in St. Louis), Tarisa L. Mantia(Washington University in St. Louis), Jane A. O’Halloran(St. Vincent's University Hospital)
Cited by 0
Related Papers
Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation
|Cell Metabolism|2016|1.5k
The continued threat of emerging flaviviruses
|Nature Microbiology|2020|1.1k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function
|Nature Immunology|2020|997